全球无菌和抗病毒包装市场规模、份额和趋势分析报告 – 行业概况和 2031 年预测

无菌及抗病毒包装市场分析

受各行业产品安全和污染控制意识增强和法规严格影响，无菌和抗病毒包装市场正在经历强劲增长。制药和医疗器械行业需要严格的无菌标准，是该市场扩张的主要推动力。医疗相关感染的日益流行和对有效感染控制措施的需求进一步推动了对先进无菌和抗病毒包装解决方案的需求。此外，包装技术的不断进步，例如开发具有内在抗菌和抗病毒特性的新型材料，正在促进市场增长。为了应对全球健康危机和消费者日益增强的卫生意识，人们越来越重视能够提供卓越防污染保护的包装解决方案。

无菌和抗病毒包装市场规模

2023 年全球无菌和抗病毒包装市场规模价值 274 亿美元，预计到 2031 年将达到 460.3 亿美元，2024 年至 2031 年预测期内的复合年增长率为 6.70%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深入的专家分析、按地理位置表示的公司生产和产能、分销商和合作伙伴的网络布局、详细和更新的价格趋势分析以及供应链和需求的缺口分析。         

报告范围和市场细分         

Sterile and Antiviral Packaging Market Definition

Sterile packaging is often created using materials and processes that ensure the complete absence of microorganisms, such as through the use of sterilization techniques like gamma radiation or ethylene oxide. Antiviral packaging, on the other hand, incorporates materials or coatings that actively inhibit the growth and spread of viruses, offering additional protection beyond traditional sterile methods.

Sterile and Antiviral Packaging Market Dynamics

Drivers

• Rising Demand for Pharmaceuticals and Medical Devices

The growing global demand for pharmaceuticals and medical devices is significantly driving the need for secure and reliable packaging solutions. This surge in demand is primarily fueled by an aging population, which requires a higher volume of medications and medical interventions, as well as increasing health awareness that prompts more individuals to seek medical care. As the pharmaceutical and medical device industries expand to meet these needs, the importance of effective packaging solutions that ensure product safety, integrity, and efficacy becomes paramount. Secure packaging is essential for protecting sensitive products from contamination and maintaining their effectiveness throughout their shelf life.         

• Increased Healthcare-Associated Infections   

As healthcare-associated infections become more prevalent, there is an urgent need for packaging that can effectively prevent contamination and support infection control efforts. Sterile medical packaging solutions that maintain a sterile environment are crucial in preventing the spread of infections within healthcare settings, where vulnerable patients are at higher risk. Advanced sterile and antiviral packaging technologies are being developed to address these concerns by incorporating materials and designs that effectively combat microbial threats. The rise in healthcare-associated infections is driving a heightened demand for packaging solutions that ensure sterility and inhibit microbial growth. 

Opportunities

• Advancements in Antiviral Materials

Ongoing research into new antiviral materials and technologies is paving the way for the development of more effective and versatile packaging solutions. Scientists and engineers are continuously exploring innovative materials that possess inherent antiviral properties or can be engineered to actively inhibit the growth and spread of viruses. These advancements include the use of novel compounds, coatings, and treatments that enhance the protective capabilities of packaging. By integrating these cutting-edge antiviral materials into packaging solutions, manufacturers can offer products that provide superior protection against viral contamination, meeting the increasing demand for safety and efficacy in various industries. This continuous evolution in antiviral technology not only improves the functionality of packaging but also opens up new opportunities for market differentiation and growth.

• Integration with Smart Packaging Technologies

Incorporating smart packaging technologies into sterile and antiviral packaging solutions represents a significant advancement in the field. Smart packaging technologies, such as sensors, indicators, and RFID tags, provide enhanced monitoring and tracking capabilities, adding a layer of functionality to traditional packaging. Sensors can detect changes in environmental conditions, such as temperature and humidity, that may affect the integrity of the product, while indicators can signal exposure to contamination or breaches in sterility. These technologies enable real-time tracking and data collection, allowing for more precise management of the packaging environment and ensuring product safety. By integrating smart features, packaging solutions can offer improved visibility, traceability, and assurance of product quality, it can also create new market opportunities for innovative and high-tech packaging solutions.

Restraints/Challenges

• High Production Costs

The development and production of advanced sterile and antiviral packaging solutions are often accompanied by high production costs, which can limit market accessibility. This cost burden arises from several factors, including the use of specialized materials that offer enhanced protective properties and the implementation of advanced manufacturing technologies. For instance, producing packaging with advanced antimicrobial or antiviral coatings requires costly raw materials and sophisticated processing techniques. These high production costs can lead to elevated retail prices, potentially restricting access to premium packaging solutions for smaller players in the market and limiting adoption among price-sensitive consumers.  

• Regulatory Compliance Challenges

Navigating the complex and varying regulatory landscape across different regions poses significant challenges for manufacturers of sterile and antiviral packaging solutions. Regulatory requirements for packaging materials, particularly those used in healthcare and food industries, are stringent and vary widely from one region to another. Compliance involves meeting specific safety, efficacy, and labeling standards, which can necessitate extensive documentation, testing, and certification processes. These regulatory hurdles can be time-consuming and costly, particularly for companies operating in multiple markets.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an analyst brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

Expected Impact of Economic Slowdown on the Pricing and Availability of Products

当经济活动放缓时，行业开始受到影响。DBMR 提供的市场洞察报告和情报服务考虑了经济衰退对产品定价和可获得性的预测影响。借助这些，我们的客户通常可以领先竞争对手一步，预测他们的销售额和收入，并估算他们的盈亏支出。

最新动态

• 2024 年 4 月，Amcor Plc 与 Kimberly Clark 合作，为其 Eco Protect 尿布推出了一种新的包装袋，其中 30% 的材料为再生材料。这些包装袋由消费后回收材料制成，为由经认证的植物纤维制成的防过敏尿布提供了更可持续的包装解决方案
• 2024 年 1 月，ProAmpac 推出了 ProActive Intelligence Moisture Protect (MP-1000)，这是一款旨在管理包装解决方案中水分含量的新产品
• 2023 年 5 月，杜邦完成了对 Spectrum Plastics Group 的收购，后者是一家专门制造特种医疗设备和部件的公司

无菌和抗病毒包装市场范围

市场根据类型和应用进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

类型

• 塑料材质
• 玻璃材质
• 金属材质
• 其他

应用

• 制药和生物
• 外科及医疗器械
• 食品和饮料包装
• 其他的

无菌和抗病毒包装区域分析

对市场进行了分析，并按上述国家、类型和应用提供了市场规模的见解和趋势。

市场报告涉及的国家包括美国、加拿大、墨西哥、巴西、阿根廷、南美洲其他地区、德国、法国、意大利、英国、比利时、西班牙、俄罗斯、土耳其、荷兰、瑞士、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新西兰、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太地区其他地区、阿联酋、沙特阿拉伯、埃及、以色列、南非以及中东和非洲其他地区

由于北美地区占据了相当大的利益相关者投资和研发份额，预计该地区将占据市场主导地位。

由于政府的优惠政策、医学科学的发展和预期寿命的增加，亚太地区预计将成为增长最快的地区。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

无菌和抗病毒包装市场份额

市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

市场上的一些主要参与者包括：

• 3M（美国）
• Anchor Packaging LLC（美国）
• Berry Global Inc.（美国）
• CeDo Ltd.（英国）
• 陶氏（美国）
• Harwal 集团公司（阿联酋）
• Intertape Polymer Group（加拿大）
• 金达尔理工学院 (印度)
• Klöckner Pentaplast（德国）
• 三菱化学公司（日本）
• Multi Wrap (Pty) Ltd.（南非）
• 肖特（德国）
• Amcor plc（瑞士）
• AptarGroup, Inc.（美国）
• Klöckner Pentaplast（德国）
• West Pharmaceutical Services, Inc.（美国）
• Berry Global Inc.（美国）
• 霍尼韦尔国际公司（美国）
• ACG（印度）
• 尼普洛（日本）
• Gerresheimer AG（德国）
• Catalent Inc.（美国）
• WestRock 公司（美国）
• 南亚塑料股份有限公司 (中国)

SKU-56048